electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025
electroCore (Nasdaq: ECOR), a commercial-stage bioelectronic technology company, has scheduled its first quarter 2025 financial results announcement for Wednesday, May 7, 2025, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
electroCore (Nasdaq: ECOR), a commercial-stage bioelectronic technology company, has scheduled its first quarter 2025 financial results announcement for Wednesday, May 7, 2025, after market close.
The company will host a webinar at 4:30 PM EST where management will review financial results and conduct a Q&A session. Investors interested in participating can access the webinar through:
- Dial-In Number: (646) 931-3860
- Webinar ID: 885 4355 1292
- Passcode: 419231
A registration link is provided for those who wish to participate and ask questions during the call.
Details
News Market Reaction – ECOR
The recorded move for ECOR in the trading session of this news was +3.30%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ROCKAWAY, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic technology company, announced today that it will report financial results for the first quarter ended March 31, 2025, after the close of the market on Wednesday, May 7, 2025.
Management will host a webinar at 4:30 PM EST to review the financial results and answer questions. Investors can access the webinar using the details below:
Wednesday, May 7, 4:30 PM EST
Dial-In: (646) 931-3860
Webinar ID: 885 4355 1292
Passcode: 419231
Registration Link: Click here to participate and ask questions on the call.
About electroCore, Inc.
electroCore, Inc. and its subsidiaries (“electroCore” or the “Company”) is a commercial stage bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies.
For more information, visit www.electrocore.com.
Contact
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.